Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Fenretinide and Lonafarnib in Treating Patients With Advanced or Recurrent Head and Neck Cancer

This study has been terminated.
(Slow Accrual.)
Sponsor:
Collaborator:
Information provided by (Responsible Party):
M.D. Anderson Cancer Center
ClinicalTrials.gov Identifier:
NCT00103090
First received: February 7, 2005
Last updated: November 12, 2012
Last verified: November 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: November 2006
  Primary Completion Date: January 2006 (Final data collection date for primary outcome measure)